Prognostic factors of overall survival of stage III or IV adrenocortical carcinomas (ACC): A multicenter ENS@T study.
Rossella Libé(Hôpital Cochin), Éric Baudin(Institut Gustave Roussy), Felix Beuschlein(University of Zurich), Martin Faßnacht(University of Würzburg), Cristina L. Ronchi(University of Birmingham), Matthias Kroiß, Barbara Zaggia(University of Turin), Isabelle Borget(Inserm), Harm R. Haak(Radboud University Nijmegen), Sophie Leboulleux(Geneva College), Marcus Quinkler(Charité - Universitätsmedizin Berlin), Arianna Ardito, Jérôme Bertherat(Centre National de la Recherche Scientifique), Margarita Bala, Delphine Vezzosi(Université Toulouse III - Paul Sabatier)
Cited by 2
Related Papers
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors
|European Journal of Endocrinology|2016|1.5k
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort
|The Lancet Diabetes & Endocrinology|2017|951
European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors
|European Journal of Endocrinology|2018|927
ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary
|Neuroendocrinology|2012|869
Combination Chemotherapy in Advanced Adrenocortical Carcinoma
|New England Journal of Medicine|2012|863